Staging Biomarkers in Preclinical Autosomal Dominant Alzheimer Disease by Estimated Years to Symptom Onset

INTRODUCTION: Staging preclinical Alzheimer disease (AD) by the expected years to symptom onset (EYO) in autosomal dominant AD (ADAD) through biomarker correlations is important. METHODS: We estimated the correlation matrix between EYO/cognition and imaging/CSF biomarkers, and searched for the EYO c...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Alzheimers Dement
Egile Nagusiak: Wang, Guoqiao, Coble, Dean, McDade, Eric M., Hassenstab, Jason, Fagan, Anne M., Benzinger, Tammie L.S., Bateman, Randall J., Morris, John C., Xiong, Chengjie
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: 2019
Gaiak:
Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC6461496/
https://ncbi.nlm.nih.gov/pubmed/30773445
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jalz.2018.12.008
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak